June 12, 2013
Pfizer Inc. said Wednesday that it has reached a $2.15 billion settlement with generic-drug makers Teva Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. to resolve more than nine years of patent litigation over the acid-reflux drug Protonix.